Key players operating in the global polymeric biomaterials market are Stryker,
BASF SE, Evonik Industries AG, DSM, Bezwada Biomedical, LLC, Corbion, Victrex plc
(Invibio Ltd.), International Polymer Engineering, Covalon Technologies Ltd.,
Medtronic, Abbott, Elixir Medical, REVA Medical, LLC, Meril Life Sciences Pvt.
Ltd., and MicroPort Scientific Corporation. With rising prevalence of chronic
diseases coupled with growing geriatric population worldwide, demand for
advanced biomaterial based medical devices and implants is increasing steadily.
Additionally, increasing healthcare expenditure in developed as well as
developing countries is driving growth of polymeric biomaterials market.
Technological advancements in material science have led to development of novel
biodegradable and bioactive polymers with improved mechanical and biological
properties, supporting adoption of biomaterial based implants and devices.
Key players operating in the
Global
Polymeric Biomaterials Market Demand are focusing on capacity expansion
and new product launches. For instance, BASF SE is investing on R&D to
develop novel biomaterials for load bearing applications. Similarly, Evonik
Industries AG acquired Resonetics to strengthen its position in medical
technologies sector. Growing demand, technological advancement and investments
by key players are expected to boost market growth during forecast period.
Market Trends:
The global polymeric biomaterials market is witnessing a trend of increasing
adoption of biodegradable polymers. Biodegradable polymers such as
poly(ε-caprolactone), poly(lactic-co-glycolic acid) offer advantages over
conventional plastics as they degrade into non-toxic components. Additionally,
advancements in fields such as tissue engineering and regenerative medicine
have augmented demand for smart biomaterial which aid in regeneration of
damaged tissues.
Market Opportunities:
Emerging economies are expected to present lucrative growth opportunities for
polymeric biomaterials market owing to growing healthcare infrastructure and
increasing healthcare spending. Moreover, rising incidence of lifestyle
diseases has augmented demand for advanced medical devices and implants in
developing countries. Furthermore, development of surface modification
techniques for polymeric biomaterials could enhance biological response and
mechanical properties, opening new growth prospects.
Impact of COVID-19 on Global Polymeric Biomaterials Market
The COVID-19 pandemic has impacted the growth of the global polymeric
biomaterials market. Strict lockdowns imposed worldwide to curb the spread of
the virus disrupted the manufacturing and supply chains of polymeric
biomaterials used in medical applications. The demand for biomaterials reduced
significantly as deferrable surgeries and procedures were postponed. This led
to decreased consumption of biomaterials used in implants, tissue engineering,
drug delivery applications during the pandemic. However, the demand rose for
polymeric membranes, particles and hydrogels used in wound care management,
diagnostics test kits and personal protective equipment.
As the pandemic progresses, the market is witnessing growing demand for
polymeric biomaterials used in medical devices, surgical kits and protection
gears to combat the virus. With increased focus on healthcare infrastructure
and biomedical research, governments and private organizations are investing
heavily in developing advanced biomaterials for diagnostic, therapeutic and
personal protective applications against COVID-19 and future pandemics. The
growing awareness about healthcare is also boosting the utilization of
biomaterials in non-emergency medical procedures that were postponed during the
pandemic's peak. While supply chain disruptions continue to impact production,
the long-term outlook of the market remains positive with the developing
COVID-19 therapies and vaccines driving consumption.
Geographical Concentration of Global Polymeric Biomaterials Market
In terms of value, North America dominated the global polymeric biomaterials
market and accounted for over 35% share in 2024. This can be attributed to the
rising prevalence of lifestyle diseases, advanced healthcare infrastructure,
and growing R&D in the field of regenerative medicines and tissue
engineering in the region. Europe and Asia Pacific respectively held the second
and third largest shares globally, led by high healthcare spending, skilled
workforce and increasing government funding for biomaterials research in
countries like Germany, UK, China and India.
Fastest Growing Region in the Global Polymeric Biomaterials Market
The Asia Pacific region is poised to witness the fastest growth in the global
polymeric biomaterials market during the forecast period of 2024 to 2031. This
can be accredited to rapidly developing healthcare sectors, growing medical
tourism industries and rising affordability of advanced treatments in emerging
economies like China, India and South Korea. Additionally, increasing
government initiatives to promote domestic biomaterials manufacturing will
further accelerate the regional market over the coming years.
Comments
Post a Comment